Table 1 Demographic and clinical characteristics at hospitalization of severe or critically ill COVID-19 patients
From: Dynamic trajectory of platelet-related indicators and survival of severe COVID-19 patients
Characteristics | NMissing (%) | Total (n = 112) | Survived (n = 81) | Dead (n = 31) |
|---|---|---|---|---|
Age [mean (SD)] | Â | 61.0 (14.9) | 57.1 (13.8) | 71.0 (13.0) |
Male [n (%)] | Â | 73 (65.2) | 54 (66.7) | 19 (61.3) |
Vital signs [mean (SD)] | ||||
 Temperature (°C) | 2 (1.8) | 37.3 (0.8) | 37.3 (0.8) | 37.2 (0.8) |
 Heart rate (beats/min) | 29 (25.9) | 89.4 (17.7) | 87.1 (16.7) | 94.4 (19.0) |
 Respiratory rate (Breaths/min) | 5 (4.5) | 24.8 (5.6) | 25.1 (5.9) | 24.1 (4.9) |
Blood pressure (mm Hg) | ||||
 Diastolic | 5 (4.5) | 73.2 (13.7) | 73.3 (14.7) | 72.8 (11.0) |
 Systolic | 5 (4.5) | 124.9 (17.3) | 124.0 (18.0) | 127.0 (15.7) |
Symptoms [n (%)] | ||||
 Fever |  | 91 (81.2) | 67 (82.7) | 24 (77.4) |
 Cough |  | 86 (76.8) | 62 (76.5) | 24 (77.4) |
 Chest tightness |  | 73 (65.2) | 56 (69.1) | 17 (54.8) |
 Fatigue |  | 65 (58.0) | 54 (66.7) | 11 (35.5) |
 Shortness of breath |  | 34 (30.4) | 21 (25.9) | 13 (41.9) |
 Phlegm |  | 28 (25.0) | 20 (24.7) | 8 (25.8) |
 Dyspnea |  | 25 (22.3) | 14 (17.3) | 11 (35.5) |
 Diarrhea |  | 19 (17.0) | 15 (18.5) | 4 (12.9) |
 Headache |  | 9 (8.0) | 7 (8.6) | 2 (6.5) |
 Myalgia |  | 6 (5.4) | 5 (6.2) | 1 (3.2) |
 Sore throat |  | 5 (4.5) | 4 (4.9) | 1 (3.2) |
 Nausea and vomiting |  | 5 (4.5) | 2 (2.5) | 3 (9.7) |
Imaging abnormalitya | Â | 18 (16.1) | 13 (16.0) | 5 (16.1) |
No. of symptoms [n (%)] | ||||
 0 |  | 2 (1.8) |  | 2 (6.5) |
 1 |  | 4 (3.6) | 4 (4.9) |  |
 2 |  | 15 (13.4) | 10 (12.3) | 5 (16.1) |
 3 |  | 20 (17.9) | 15 (18.5) | 5 (16.1) |
 4 |  | 30 (26.8) | 23 (28.4) | 7 (22.6) |
 5 |  | 23 (20.5) | 16 (19.8) | 7 (22.6) |
 6 |  | 12 (10.7) | 8 (9.9) | 4 (12.9) |
 ≥ 7 |  | 6 (5.4) | 5 (6.2) | 1 (3.2) |
Comorbidities [n (%)] | ||||
 Hypertension |  | 40 (35.7) | 26(32.1) | 14 (45.2) |
 Respiratory failure |  | 27 (24.1) | 16 (19.8) | 11 (35.5) |
 Cardiovascular disease |  | 17 (15.2) | 10 (12.3) | 7 (22.6) |
 Diabetes |  | 21 (18.8) | 15 (18.5) | 6 (19.4) |
 Acute lung injury |  | 14 (12.5) | 9 (11.1) | 5 (16.1) |
 COPDb |  | 5 (4.5) | 2 (2.5) | 3 (9.7) |
 Bacterial pneumonia |  | 3 (2.7) | 2 (2.5) | 1 (3.2) |
 Hepatic injury |  | 3 (2.7) | 3 (3.7) |  |
 Septic shock |  | 3 (2.7) | 2 (2.5) | 1 (3.2) |
 Cerebral infarction |  | 2 (1.8) | 1 (1.2) | 1 (3.2) |
 Acute kidney injury |  | 1 (0.9) | 1 (1.2) |  |
 Cerebral hemorrhage |  | 1 (0.9) | 1 (1.2) |  |
 Sepsis |  | 1 (0.9) | 1 (1.2) |  |
N of comorbidities [n (%)] | ||||
 0 |  | 46 (41.1) | 36 (44.4) | 10 (32.3) |
 1 |  | 26 (23.2) | 20 (24.7) | 6 (19.4) |
 2 |  | 19 (17.0) | 13 (16.0) | 6 (19.4) |
 3 |  | 13 (11.6) | 7 (8.6) | 6 (19.4) |
 4 |  | 4 (3.6) | 2 (2.5) | 2 (6.5) |
 5 |  | 1 (0.9) | 1 (1.2) | 0 (0) |
 ≥ 6 |  | 3 (2.7) | 2 (2.5) | 1 (3.2) |
Worst severity in hospital | ||||
 Severe |  | 63 | 63 | 0 |
 Critical illness [n (%)] |  | 49 | 18 | 31 |